jiliko sign up
Biden says Assad's fall in Syria is a 'fundamental act of justice,' but 'a moment of risk'
CONWAY, Ark., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (NYSE: HOMB) (“Home” or “the Company”), and its wholly-owned subsidiary, Centennial Bank (“Centennial”), announced it has established additional reserves for loan losses as a result of Hurricane Milton. On October 11, 2024, HOMB announced a $16.7 million reserve as a result of Hurricane Helene, which made landfall September 26, 2024. Upon announcement HOMB indicated the more recent and powerful Hurricane Milton, which made landfall on October 9, 2024, and caused the spin-off of more than two dozen tornados, would likely lead to an increase in this reserve amount. “Out of an abundance of caution, HOMB has decided to make an additional $16.7 million reserve following the second Florida hurricane, bringing our total hurricane reserve to $33.4 million for the year,” said John Allison, Chairman of HOMB. “The two hurricanes spanned across the third and fourth quarter and the amount of time it takes for customers to settle with insurance will no doubt increase, with two back-to-back events,” continued Allison. “We have approximately $110 million currently on deferral as a result of the two hurricanes and in keeping with our conservative nature, we feel as though this proactive move is a prudent and predictable course of action,” added Allison. Branches The Company currently has 76 branches in Arkansas, 78 branches in Florida, 58 branches in Texas, 5 branches in Alabama and one branch in New York City. About Home BancShares Home BancShares, Inc. is a bank holding company, headquartered in Conway, Arkansas. Its wholly-owned subsidiary, Centennial Bank, provides a broad range of commercial and retail banking plus related financial services to businesses, real estate developers, investors, individuals and municipalities. Centennial Bank has branch locations in Arkansas, Florida, Texas, South Alabama and New York City. The Company’s common stock is traded through the New York Stock Exchange under the symbol “HOMB.” The Company was founded in 1998. Visit www.homebancshares.com or www.my100bank.com for more information. General This release contains forward-looking statements regarding the Company’s plans, expectations, goals and outlook for the future, including future financial results. Statements in this press release that are not historical facts should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future events, performance or results. When we use words or phrases like “may,” “plan,” “propose,” “contemplate,” “anticipate,” “believe,” “intend,” “continue,” “expect,” “project,” “predict,” “estimate,” “could,” “should,” “would,” “on track” and similar expressions, you should consider them as identifying forward-looking statements, although we may use other phrasing. Forward-looking statements of this type speak only as of the date of this news release. By nature, forward-looking statements involve inherent risks and uncertainties. Various factors could cause actual results to differ materially from those contemplated by the forward-looking statements. These factors include, but are not limited to, the following: economic conditions, credit quality, interest rates, loan demand, real estate values and unemployment, including the ongoing impacts of inflation; the ability to identify, complete and successfully integrate new acquisitions; the risk that expected cost savings and other benefits from acquisitions may not be fully realized or may take longer to realize than expected; diversion of management time on acquisition-related issues; the availability of and access to capital and liquidity on terms acceptable to us; legislative and regulatory changes and risks and expenses associated with current and future legislation and regulations; technological changes and cybersecurity risks and incidents; the effects of changes in accounting policies and practices; changes in governmental monetary and fiscal policies; political instability, military conflicts and other major domestic or international events; the impact of recent or future adverse weather events, including hurricanes, and other natural disasters; disruptions, uncertainties and related effects on credit quality, liquidity and other aspects of our business and operations that may result from any future public health crises; competition from other financial institutions; potential claims, expenses and other adverse effects related to current or future litigation, regulatory examinations or other government actions; potential increases in deposit insurance assessments, increased regulatory scrutiny or market disruptions resulting from financial challenges in the banking industry; changes in the assumptions used in making the forward-looking statements; and other factors described in reports we file with the Securities and Exchange Commission (the “SEC”), including those factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 26, 2024. FOR MORE INFORMATION CONTACT: Donna Townsell Director of Investor Relations Home BancShares, Inc. (501) 328-4625
CHICAGO — Zach LaVine scored 26 points, Ayo Dosunmu and Coby White each had 20 and the Chicago Bulls beat the Atlanta Hawks 136-122 on Friday night in an NBA Cup game. Nikola Vucevic had 18 points and 13 rebounds for his 11th double-double and Josh Giddey scored 18 as all five Chicago starters — and two bench players — reached double figures. The Bulls shot a season-high 57% (49 of 86) from the floor The Bulls beat Atlanta for the second time this season and improved to 1-1 in NBA Cup play. Chicago won in the in-season tournament after going 0-4 last season. Trae Young had 25 points and 13 assists for Atlanta, while Jalen Johnson finished with 25 points and 13 rebounds. Clint Capela had 21 points and 11 rebounds as the Hawks closed out a four-game trip at 1-3. Atlanta is 2-1 in NBA Cup play. Takeaways Hawks: Bogdan Bogdanovic came off the bench to score 16 points, including four 3-pointers, to give Atlanta a lift. Bulls. Forward Patrick Williams missed a second straight game with inflammation in his left foot, and Dosunmu took his place in the starting lineup. Coach Billy Donovan didn’t have a timeline for Williams’ return. Williams missed the second half of last season with acute bone edema in the foot, then a stress reaction that required surgery. Atlanta Hawks' Jalen Johnson blocks the shot of Chicago Bulls' Dalen Terry during the second half of an Emirates NBA Cup basketball game Friday, Nov. 22, 2024, in Chicago. Credit: AP/Charles Rex Arbogast Key Moment Jalen Smith came of the bench to hit three straight 3-pointers early in the fourth to make it 109-90. Smith finished with 13 points. Key Stat Atlanta had 14 offensive rebounds to five for Chicago. That helped the Hawks generate second chances to keep it close early. Up next The Hawks play Dallas in Atlanta on Monday. The Bulls host Memphis on Saturday.With December ticking toward its end, 2024 is just about ready to fall off the calendar. It's been an absolutely wonderful performance stretch for the broader market, and hot tech companies including Nvidia , Palantir , and Apple have rocketed to new valuation highs. But there are also some great technology stocks out there that are trading well below previous pricing heights, and investors could be doing themselves a disservice by overlooking these great companies. If you're on the hunt for investments that can deliver big wins in 2025 and beyond, read on to see why two Fool.com contributors think these beaten-down stocks are great buys right now. AMD is an undervalued AI stock play Keith Noonan : Advanced Micro Devices ( AMD 0.10% ) is a designer of central processing units (CPUs) and GPUs for personal computers and data centers. The company's stock is up roughly 182% over the last five years thanks to some solid business execution and excitement that the company could be poised to see some of the same explosive, AI-driven growth that has propelled Nvidia to stellar returns. On the other hand, AMD has seen a slower ramping for AI-related processors than some investors expected -- and the disconnect in the timeline has caused some significant valuation pullback for the stock. The chip specialist's share price is now down roughly 40% from the lifetime high that it hit earlier this year. Despite a strong rally for the broader market, AMD stock has tumbled over the last few months -- and the company's share price has yet to recover from sell-offs triggered by its third-quarter earnings release at the end of October. AMD's revenue grew roughly 18% year over year to reach $6.8 billion in the period. Meanwhile, non-GAAP (adjusted) earnings per share rose 31% compared to the prior-year period. While AMD will continue to have a strong market presence in processors for gaming and personal computers, it's the data center segment that has really become central to the stock's performance. Last quarter saw sales for the AI-related segment increase to $3.5 billion -- up 122% year over year and 25% on a sequential quarterly basis. The performance actually topped Wall Street's expectations and pushed the business to overall sales and earnings beats in the quarter, but some investors and analysts didn't think the company's guidance was bullish enough. AMD has tended to err on the conservative side lately when it comes to issuing guidance, and it wouldn't be surprising to see significant near-term gains kicked off by Q4 numbers that come in better than broadly expected. But more importantly for long-term investors, the business remains poised to benefit from the unfolding AI revolution. The company's competitive positioning in the highly lucrative GPU category isn't as as strong as Nvidia's, but AMD's lagging stock performance opens the door for investors who buy shares at today's prices to see big gains. Aehr Test Systems is a buy for enterprising investors Lee Samaha : It's fair to say it hasn't been a vintage year for the provider of burn-in testing equipment to the chip industry. Aehr Test Systems ( AEHR 1.35% ) makes silicon carbide chip testing equipment, and its primary growth market comes from its use in electric vehicles ( EVs ). Silicon carbide chips have qualities that make them more efficient than silicon in power electronics, making them ideal for EVs. There's little doubt that the adoption of silicon carbide chips will grow, fueling demand for Aehr's solutions. However, growth expectations for both the chips and Aehr's sales have been pared back this year due to the slowing growth of EV sales, which has caused automakers to defer investment in production lines. As a result, the company's share price is down roughly 72% from its lifetime high as of this writing. Still, the slowdown -- primarily related to relatively high interest rates -- is unlikely to last forever, and no one disputes that EVs are the transportation industry's future. In addition, Aehr recently inked a deal to sell an initial $10 million worth of equipment to an artificial intelligence customer. The agreement helps diversify Aehr's end markets and customer base and de-risks the stock. With the company successfully opening new end markets and a likely recovery in its EV end markets, Aehr Test Systems has plenty of potential to grow. Now could be an opportune time to buy the stock.
School board removes jeewan chanicka's podcast, officially announces interim directorPublished 5:16 pm Friday, November 22, 2024 By Data Skrive For those looking to wager on the upcoming game between the Minnesota Wild and the Calgary Flames on Saturday at 4:00 PM ET, is Matthew Boldy a player who is likely light the lamp? We analyze all the numbers in the article below. Sign up for ESPN+ today to watch 1,000+ out-of-market NHL games, ESPN+ Hockey Night & more. Odds to score a goal this game: +175 (Bet $10 to win $17.50 if he scores a goal) Place your bets on any NHL matchup at BetMGM. Sign up today using our link. Catch NHL action all season long on Fubo. Catch NHL action all season long on Max. Bet on this or any NHL matchup at BetMGM. Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER .
Syrian Rebels Say They Have Encircled Capital; Russia, Trump Weigh InVictor Wembanyama Injury Status – Spurs vs. Pelicans Injury Report December 8
franz12 L'Oréal ( OTCPK:LRLCF , OTCPK:LRLCY ) is a world's leading cosmetics and beauty company with a current market cap at 180bn+. With 90,000+ employees, a presence in 150+ countries and 37 global brands, this company has been in operation for nearly 115 years - it is easy Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. The articles represents my own opinions and has no relation to any company whatsoever. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Neogen Co. ( NASDAQ:NEOG – Free Report ) by 17.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 38,166 shares of the company’s stock after purchasing an additional 5,804 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Neogen were worth $642,000 at the end of the most recent quarter. Several other institutional investors and hedge funds also recently bought and sold shares of NEOG. Inspire Investing LLC raised its stake in shares of Neogen by 2.7% in the second quarter. Inspire Investing LLC now owns 26,074 shares of the company’s stock worth $408,000 after buying an additional 685 shares during the period. Stephens Inc. AR raised its stake in Neogen by 2.6% during the 3rd quarter. Stephens Inc. AR now owns 35,930 shares of the company’s stock worth $604,000 after acquiring an additional 909 shares during the period. Arizona State Retirement System lifted its holdings in Neogen by 1.9% during the second quarter. Arizona State Retirement System now owns 57,609 shares of the company’s stock valued at $900,000 after purchasing an additional 1,079 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Neogen by 142.6% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,982 shares of the company’s stock worth $33,000 after purchasing an additional 1,165 shares during the period. Finally, Commonwealth Equity Services LLC increased its stake in shares of Neogen by 3.4% in the second quarter. Commonwealth Equity Services LLC now owns 36,630 shares of the company’s stock worth $573,000 after purchasing an additional 1,190 shares in the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors. Neogen Stock Up 3.6 % Shares of NEOG opened at $12.82 on Friday. The business’s 50 day moving average is $14.59 and its 200 day moving average is $15.58. The company has a current ratio of 4.41, a quick ratio of 2.79 and a debt-to-equity ratio of 0.28. Neogen Co. has a 12-month low of $11.46 and a 12-month high of $20.89. The company has a market capitalization of $2.78 billion, a PE ratio of -116.55 and a beta of 1.21. Insiders Place Their Bets In other news, CEO John Edward Adent bought 14,500 shares of Neogen stock in a transaction dated Friday, October 11th. The shares were purchased at an average cost of $13.80 per share, with a total value of $200,100.00. Following the completion of the acquisition, the chief executive officer now owns 216,477 shares of the company’s stock, valued at $2,987,382.60. This trade represents a 7.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website . Corporate insiders own 1.13% of the company’s stock. Wall Street Analyst Weigh In Separately, StockNews.com raised shares of Neogen to a “sell” rating in a report on Monday, September 30th. Read Our Latest Report on Neogen Neogen Profile ( Free Report ) Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. See Also Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. ( NASDAQ:NEOG – Free Report ). Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter .Downtown Colorado Springs diner announces closure at year's endAn archbishop's knock formally restores Notre Dame to life as winds howl and heads of state look on
NEW YORK: A 26-year-old man was arrested and charged with murder Monday in the targeted killing of a health insurance executive on the streets of New York, along with other violations. Luigi Mangione was charged in New York on suspicion of one count of murder, two counts of second-degree criminal possession of a weapon, one count of second-degree possession of a forged document and one count of third-degree possession of a weapon, according to online court documents seen by AFP. Investigators continued to interrogate Mangione in connection with last week’s brazen murder, which triggered a nationwide manhunt and global headlines. He arrived at a Pennsylvania court wearing a dark sweatshirt after 6:00 pm (2300 GMT) Monday and was led inside by Altoona police flanked by NYPD detectives where he was arraigned, broadcasters showed. Mangione is next due to appear in court on Dec 23. Pennsylvania Governor Josh Shapiro said that murder charges in New York state would follow, telling a media briefing “we do not kill people in cold blood to resolve policy differences or express a viewpoint”. Police have not confirmed reports the words “delay” and “deny” — language used by insurers to reject claims — were written on casings found at the scene, hinting at a possible political motive for the crime. According to a New York Times report citing friends of Mangione, the suspect lived with serious back pain and underwent surgery for the condition last year. A photo on what appeared to be one of his social media accounts included an X-ray of an apparently injured spine. Mangione was apprehended by officers following a tip from staff at an Altoona McDonald’s branch, where he was found wearing a mask and a beanie while using a laptop, and gave officers a fake ID, charging documents show. They then searched him and found what police called a “ghost gun” capable of firing 9mm rounds and equipped with a suppressor that could have been made on a 3D printer. When officers asked if he had been to New York recently, Mangione “became quiet and started to shake”, according to the criminal complaint. One of the fake IDs found was that used to check in to a Manhattan hostel ahead of the attack, discovered alongside a document that spoke to Mangione’s “motivation and mindset”, New York police said. Mangione was born and raised in Maryland, studied at the Ivy League University of Pennsylvania, and had been living in Hawaii ahead of the killing. Mangione’s LinkedIn profile showed he worked as a data engineer at TrueCar, a California-based online auto marketplace that said he left their employment in 2023. “Our family is shocked and devastated by Luigi’s arrest,” the Mangione family said in a statement posted on Maryland politician Nino Mangione’s site on X. In last Wednesday’s shooting, the gunman walked up behind Brian Thompson, a senior executive at UnitedHealthcare — one of the country’s largest medical insurers — and shot him dead in front of bystanders. The attack was captured by a surveillance camera and the footage seen by millions around the world, as interest in the manhunt and mystery over the killer’s motives built to a frenzy. Thompson, 50, was attending an investor conference in the Midtown business district. Detectives said the suspect fled the crime scene on foot before riding a bike to Central Park and later boarding a bus from a terminal in the north of the city connecting New York to surrounding states and beyond. Video footage shows Thompson on the sidewalk outside the New York Hilton Midtown when a man in a hooded top, his lower face covered, approaches from behind and fires several shots at the father-of-two, who crumples to the ground. An image released of the suspect was obtained from the youth hostel where the gunman apparently stayed before the hit, with media reporting he had lowered his mask to flirt with a receptionist. The highly profitable US medical insurance system is the source of deep frustration and anger among many Americans, due to its steep costs and limited coverage, and Thompson’s death was greeted with an absence of sympathy by some. A Facebook post mourning his loss, shared by UnitedHealth Group, racked up more than 71,000 laugh emojis within two days before the counter was disabled. Mangione must now be extradited from Pennsylvania to New York to face murder charges, police said. – AFPAs part of a national “moonshot” to cure blindness, researchers at the CU Anschutz Medical Campus will receive as much as $46 million in federal funding over the next five years to pursue a first-of-its-kind full eye transplantation. “This is no easy undertaking, but I believe we can achieve this together,” said Dr. Kia Washington, the lead researcher for the University of Colorado-led team, during a press conference Monday. “And in fact I’ve never been more hopeful that a cure for blindness is within reach.” The CU team was one of four in the United States that received funding awards from the federal Advanced Research Projects Agency for Health , or ARPA-H. The CU-based group will focus on achieving the first-ever vision-restoring eye transplant by using “novel stem cell and bioelectronic technologies,” according to a news release announcing the funding. The work will be interdisciplinary, Washington and others said, and will link together researchers at institutions across the country. The four teams that received the funding will work alongside each other on distinct approaches, though officials said the teams would likely collaborate and eventually may merge depending on which research avenues show the most promise toward achieving the ultimate goal of transplanting an eye and curing blindness. Dr. Calvin Roberts, who will oversee the broader project for ARPA-H, said the agency wanted to take multiple “shots on goal” to ensure progress. “In the broader picture, achieving this would be probably the most monumental task in medicine within the last several decades,” said Dr. Daniel Pelaez of the University of Miami’s Bascom Palmer Eye Institute, which also received ARPA-H funding. Pelaez is the lead investigator for that team, which has pursued new procedures to successfully remove and preserve eyes from donors, amid other research. He told The Denver Post that only four organ systems have not been successfully transplanted: the inner ear, the brain, the spinal cord and the eye. All four are part of the central nervous system, which does not repair itself when damaged. If researchers can successfully transplant the human eye and restore vision to the patient, it might help unlock deeper discoveries about repairing damage to the brain and spine, Pelaez said, as well as addressing hearing loss. To succeed, researchers must successfully remove and preserve eyes from donors and then successfully connect and repair the optical nerve, which takes information from the eye and tells the brain what the eye sees. A team at New York University performed a full eye transplant on a human patient in November 2023, though the procedure — while a “remarkable achievement,” Pelaez said — did not restore the patient’s vision. It was also part of a partial face transplant; other approaches pursued via the ARPA-H funding will involve eye-specific transplants. Washington, the lead CU researcher, said she and her colleagues have already completed the eye transplant procedure — albeit without vision restoration — in rats. The CU team will next work on large animals to advance “optic nerve regenerative strategies,” the school said, as well as to study immunosuppression, which is critical to ensuring that patients’ immune systems don’t reject a donated organ. The goal is to eventually advance to human trials. Pelaez and his colleagues have completed their eye-removal procedure in cadavers, he said, and they’ve also studied regeneration in several animals that are capable of regenerating parts of their eyes, like salamanders or zebra fish. His team’s funding will focus in part on a life-support machine for the eye to keep it healthy and viable during the removal process. InGel Therapeutics, a Massachusetts-based Harvard spinoff and the lead of a third team, will pursue research on 3-D printed technology and “micro-tunneled scaffolds” that carry certain types of stem cells as part of a focus on optical nerve regeneration and repair, ARPA-H said. ARPH-A, created two years ago, will oversee the teams’ work. Researchers at 52 institutions nationwide will also contribute to the teams. The CU-led group will include researchers from the University of Southern California, the University of Wisconsin, Indiana University and Johns Hopkins University, as well as from the National Eye Institute . The teams will simultaneously compete and collaborate: Pelaez said his team has communicated with researchers at CU and at Stanford, another award recipient, about their eye-removal research. The total funding available for the teams is $125 million, ARPA-H officials said Monday, and it will be distributed in phases, in part dependent on teams’ success. U.S. Rep. Diana DeGette, a Democrat who represents Denver in Congress, acknowledged the recent election results at the press conference Monday and pledged to continue fighting to preserve ARPA-H’s funding under President-elect Donald Trump’s administration. The effort to cure blindness, Washington joked, was “biblical” in its enormity — a reference to the Bible story in which Jesus cures a blind man. She and others also likened it to a moonshot, meaning the effort to successfully put Neil Armstrong and Buzz Aldrin on the moon nearly 50 years ago. If curing blindness is similar to landing on the moon, then the space shuttle has already left the launchpad, Washington said. “We have launched,” she said, “and we are on our trajectory.” Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Most Popular A shooter kills UnitedHealthcare’s CEO in an ambush in New York, police say A shooter kills UnitedHealthcare’s CEO in an ambush in New York, police say Amazon same-day delivery center opens in Hampton — the 1st of its kind in Hampton Roads Amazon same-day delivery center opens in Hampton — the 1st of its kind in Hampton Roads Amber Alert: 3 children in extreme danger last seen at Augusta County bus stop, police say Amber Alert: 3 children in extreme danger last seen at Augusta County bus stop, police say Here are the top 50 high school football recruits in Hampton Roads’ Class of 2025 Here are the top 50 high school football recruits in Hampton Roads’ Class of 2025 ‘Deny,’ ‘defend’ and ‘depose’: Ammunition used in CEO’s killing had writing on it, AP source says ‘Deny,’ ‘defend’ and ‘depose’: Ammunition used in CEO’s killing had writing on it, AP source says John Hinckley Jr., who tried to kill Ronald Reagan, announces plans to open music store in Williamsburg John Hinckley Jr., who tried to kill Ronald Reagan, announces plans to open music store in Williamsburg Newport News retiree warns of losing access to doctors under city’s insurance provider Newport News retiree warns of losing access to doctors under city’s insurance provider German restaurant Deutsche Ecke opens in Newport News German restaurant Deutsche Ecke opens in Newport News Attend the German Christmas Market this weekend in Newport News Attend the German Christmas Market this weekend in Newport News The latest business openings and closings in Hampton Roads The latest business openings and closings in Hampton Roads Trending Nationally UnitedHealthcare CEO Brian Thompson killed by masked gunman outside NYC hotel Pennsylvania-based Yuengling, the oldest brewery in America, is bringing its beer to Chicago Maverick operator of California raw milk dairy that sickened children could have role in Trump’s FDA DeSantis interested in Defense secretary job, replacing Hegseth: insider Hugh Jackman’s ex-wife not ready for ‘blended’ family with Sutton Foster
Trump meets with Macron, Zelenskyy ahead of Notre Dame reopening ceremony in ParisResearchers launch “moonshot” to cure blindness through eye transplants
INDIANAPOLIS — There's more than just school pride and bragging rights to all that bellyaching over who might be in and who might be out of college football 's first 12-team playoff. Try the more than $115 million that will be spread across the conferences at the end of the season, all depending on who gets in and which teams go the farthest. According to the College Football Playoff website , the 12 teams simply making the bracket earn their conferences $4 million each. Another $4 million goes to conferences whose teams get into the quarterfinals. Then, there's $6 million more for teams that make the semifinals and another $6 million for those who play for the title. Most of this bonanza comes courtesy of ESPN, which is forking over $1.3 billion a year to televise the new postseason. A lot of that money is already earmarked — more goes to the Big Ten and Southeastern Conference than the Big 12 or Atlantic Coast — but a lot is up for grabs in the 11 games that will play out between the opening round on Dec. 20 and the final on Jan. 20. In all, the teams that make the title game will bring $20 million to their conferences, all of which distribute that money, along with billions in TV revenue and other sources, in different ways. In fiscal 2022-23, the Big Ten, for instance, reported revenue of nearly $880 million and distributed about $60.5 million to most of its members. The massive stakes might help explain the unabashed lobbying coming from some corners of the football world, as the tension grows in advance of Sunday's final rankings, which will set the bracket. Earlier this week, Big 12 commissioner Brett Yormark lit into the selection committee, which doesn't have a single team higher than 15 in the rankings. That does two things: It positions the Big 12 as a one-bid league, and also threatens to makes its champion — either Arizona State or Iowa State — the fifth-best among conference titlists that get automatic bids. Only the top four of those get byes, which could cost the Big 12 a spot in the quarterfinals — or $4 million. “The committee continues to show time and time again that they are paying attention to logos versus resumes,” Yormark said this week, while slamming the idea of teams with two losses in his conference being ranked worse than teams with three in the SEC. The ACC is also staring at a one-bid season with only No. 8 SMU inside the cut line of this week's projected bracket. Miami's loss last week all but bumped the Hurricanes out of the playoffs, a snub that ACC commissioner Jim Phillips said left him “incredibly shocked and disappointed." “As we look ahead to the final rankings, we hope the committee will reconsider and put a deserving Miami in the field," Phillips said in a statement. The lobbying and bickering filters down to the campuses that feel the impact. And, of course, to social media. One of the most entertaining episodes came earlier this week when athletic directors at Iowa State and SMU went back and forth about whose team was more deserving. There are a few stray millions that the selection committee cannot really influence, including a $3 million payment to conferences that make the playoff. In a reminder that all these kids are going to school, after all, the conferences get $300,000 per football team that meets academic requirements to participate in the postseason. (That's basically everyone). ___ Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football
Who doesn’t love the idea of earning steady, high income from their stock investments? Whether the stock market is rallying or pulling back, high-yield tend to continue rewarding investors with consistent cash flow. This is because dividend-paying companies are usually established players with a strong track record of returning value to shareholders. In this article, I’ll introduce you to two high-yield Canadian dividend stocks paying over 6% right now and explain why they could be excellent additions to your income-focused portfolio. Gibson Energy stock The first high-yield dividend stock in my list is ( ). This Calgary-headquartered energy company mainly focuses on midstream oil and gas operations, which include storing, transporting, and marketing crude oil and refined products. After rallying by over 19% so far in 2024, GEI stock currently trades at $34.03 per share with a of $3.9 billion. At this market price, it offers a 6.8% annualized dividend yield. This impressive dividend yield of over 6% is backed by Gibson’s strong financial and operational performance as it continues to ensure stability even in a challenging economic environment. For example, the company’s infrastructure segment, which now makes up over 85% of its business, registered a 7% year-over-year increase in its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) in the latest quarter ended in September 2024. As a result, Gibson’s adjusted EBITDA margin also expanded to 5.2% last quarter compared to 4.6% a year ago. This growth was mainly fueled by record crude volumes at its Edmonton Terminal, supported by connections to key pipelines like the Trans Mountain Expansion. Another key factor that makes Gibson an attractive, high-yield dividend stock to buy now is its solid cash flow and disciplined approach to shareholder returns. Despite a slight dip in distributable cash flow in the most recent quarter, the company maintained a conservative dividend payout ratio of 65%. Moreover, Gibson’s strong portfolio of strategic assets across Canada and the United States could help it post strong financial growth in the coming years, which should also help its share prices appreciate in value. Veren stock Besides Gibson Energy, ( ), which was earlier known as Crescent Point Energy, could be a high-yield dividend stock Canadian investors may want to consider on the dip right now. After witnessing 22% value erosion year to date, VRN stock currently trades at $7.15 per share with a market cap of $4.4 billion. These declines, however, have made the company’s dividend yield even more attractive, currently at 6.2%. Despite some production hiccups due to unplanned downtime and facility constraints this year, Veren has maintained a disciplined approach to capital allocation. In the third quarter, the company generated $114 million in excess cash flow and expects to achieve $625 million for the full year. Interestingly, it has managed to reduce its net debt by $1.3 billion so far in 2024, reflecting its focus on strengthening its balance sheet. Moreover, Veren’s top assets, like Alberta Montney and Kaybob Duvernay, are continuing to pay off, with a strong performance from top-tier wells and efficiency gains in its drilling techniques, brightening its long-term growth outlook.Atlassian CEO Michael Cannon-Brookes sells $2.19 million in stockUnion County discusses use of AI in Right to Know requestsJulia Bradbury on lifestyle change and going teetotal after cancer diagnosis
Abortion has become slightly more common despite bans or deep restrictions in most Republican-controlled states, and the legal and political fights over its future are not over yet. It's now been two and a half years since the U.S. Supreme Court overturned Roe v. Wade and opened the door for states to implement bans. The policies and their impact have been in flux ever since the ruling in Dobbs v. Jackson Women's Health Organization. Here's a look at data on where things stand: Overturning Roe and enforcing abortion bans has changed how woman obtain abortions in the U.S. But one thing it hasn't done is put a dent in the number of abortions being obtained. There have been slightly more monthly abortions across the country recently than there were in the months leading up to the June 2022 ruling, even as the number in states with bans dropped to near zero. “Abortion bans don’t actually prevent abortions from happening,” said Ushma Upadhyay, a public health social scientist at the University of California San Francisco. But, she said, they do change care. For women in some states, there are major obstacles to getting abortions — and advocates say that low-income, minority and immigrant women are least likely to be able to get them when they want. For those living in states with bans, the ways to access abortion are through travel or abortion pills. As the bans swept in, abortion pills became a bigger part of the equation. They were involved in about half the abortions before Dobbs. More recently, it’s been closer to two-thirds of them, according to research by the Guttmacher Institute. The uptick of that kind of abortion, usually involving a combination of two drugs, was underway before the ruling. But now, it's become more common for pill prescriptions to be made by telehealth. By the summer of 2024, about 1 in 10 abortions was via pills prescribed via telehealth to patients in states where abortion is banned. As a result, the pills are now at the center of battles over abortion access. This month, Texas sued a New York doctor for prescribing pills to a Texas woman via telemedicine. There's also an effort by Idaho, Kansas and Missouri to roll back their federal approvals and treat them as “controlled dangerous substances,” and a push for the federal government to start enforcing a 19th-century federal law to ban mailing them. Clinics have closed or halted abortions in states with bans. But a network of efforts to get women seeking abortions to places where they're legal has strengthened and travel for abortion is now common. The Guttmacher Institute found that more than twice as many Texas residents obtained abortion in 2023 in New Mexico as New Mexico residents did. And as many Texans received them in Kansas as Kansans. Abortion funds, which benefitted from “rage giving” in 2022, have helped pay the costs for many abortion-seekers. But some funds have had to cap how much they can give . Since the downfall of Roe, the actions of lawmakers and courts have kept shifting where abortion is legal and under what conditions. Here's where it stands now: Florida, the nation’s third most-populous state, began enforcing a ban on abortions after the first six weeks of pregnancy on May 1. That immediately changed the state from one that was a refuge for other Southerners seeking abortion to an exporter of people looking for them. There were about 30% fewer abortions there in May compared with the average for the first three months of the year. And in June, there were 35% fewer. While the ban is not unique, the impact is especially large. The average driving time from Florida to a facility in North Carolina where abortion is available for the first 12 weeks of pregnancy is more than nine hours, according to data maintained by Caitlin Myers, a Middlebury College economics professor. The bans have meant clinics closed or stopped offering abortions in some states. But some states where abortion remains legal until viability – generally considered to be sometime past 21 weeks of pregnancy , though there’s no fixed time for it – have seen clinics open and expand . Illinois, Kansas and New Mexico are among the states with new clinics. There were 799 publicly identifiable abortion providers in the U.S. in May 2022, the month before the Supreme Court reversed Roe v. Wade. And by this November, it was 792, according to a tally by Myers, who is collecting data on abortion providers. But Myers says some hospitals that always provided some abortions have begun advertising it. So they’re now in the count of clinics – even though they might provide few of them. How hospitals handle pregnancy complications , especially those that threaten the lives of the women, has emerged as a major issue since Roe was overturned. President Joe Biden's administration says hospitals must offer abortions when they're needed to prevent organ loss, hemorrhage or deadly infections, even in states with bans. Texas is challenging the administration’s policy and the U.S. Supreme Court this year declined to take it up after the Biden administration sued Idaho. More than 100 pregnant women seeking help in emergency rooms and were turned away or left unstable since 2022, The Associated Press found in an analysis of federal hospital investigative records. Among the complaints were a woman who miscarried in the lobby restroom of Texas emergency room after staff refused to see her and a woman who gave birth in a car after a North Carolina hospital couldn't offer an ultrasound. The baby later died. “It is increasingly less safe to be pregnant and seeking emergency care in an emergency department,” Dara Kass, an emergency medicine doctor and former U.S. Health and Human Services official told the AP earlier this year. Since Roe was overturned, there have been 18 reproductive rights-related statewide ballot questions. Abortion rights advocates have prevailed on 14 of them and lost on four. In the 2024 election , they amended the constitutions in five states to add the right to abortion. Such measures failed in three states: In Florida, where it required 60% support; in Nebraska, which had competing abortion ballot measures; and in South Dakota, where most national abortion rights groups did support the measure. AP VoteCast data found that more than three-fifths of voters in 2024 supported abortion being legal in all or most cases – a slight uptick from 2020. The support came even as voters supported Republicans to control the White House and both houses of Congress. Associated Press writers Linley Sanders, Amanda Seitz and Laura Ungar contributed to this article.Maharashtra: Devendra Fadnavis counters Sharad Pawar’s vote-seat discrepancy claims
- Previous: jiliko gcash
- Next: jiliko world
